191 related articles for article (PubMed ID: 34118806)
1. 1,25-dihydroxyvitamin D3 regulates t helper and b lymphocyte responses substantially in drug-naive primary Sjögren’s syndrome patients’ mononuclear cells.
Genç D; Sezer Kürkçü M; Günaydın B; Tarhan EF
Turk J Med Sci; 2021 Oct; 51(5):2467-2476. PubMed ID: 34118806
[TBL] [Abstract][Full Text] [Related]
2. Immunoregulatory effects of dental mesenchymal stem cells on T and B lymphocyte responses in primary Sjögren's syndrome.
Genç D; Günaydın B; Sezgin S; Aladağ A; Tarhan EF
Immunotherapy; 2022 Mar; 14(4):225-247. PubMed ID: 35012368
[TBL] [Abstract][Full Text] [Related]
3. CD4+CXCR5+ follicular helper T cells in salivary gland promote B cells maturation in patients with primary Sjogren's syndrome.
Jin L; Yu D; Li X; Yu N; Li X; Wang Y; Wang Y
Int J Clin Exp Pathol; 2014; 7(5):1988-96. PubMed ID: 24966908
[TBL] [Abstract][Full Text] [Related]
4. Peripheral regulatory cells immunophenotyping in primary Sjögren's syndrome: a cross-sectional study.
Furuzawa-Carballeda J; Hernández-Molina G; Lima G; Rivera-Vicencio Y; Férez-Blando K; Llorente L
Arthritis Res Ther; 2013; 15(3):R68. PubMed ID: 23800367
[TBL] [Abstract][Full Text] [Related]
5. Influence of total glucosides of paeony on PD-1/PD-L1 expression in primary Sjögren's syndrome.
Chen Y; Wang Y; Xu L; Zhu W; Xu C; Xu M; Guo L; Hu W; Xu D; Jing R; Zhu Y; He J; Xu B
Int J Rheum Dis; 2019 Feb; 22(2):200-206. PubMed ID: 30338648
[TBL] [Abstract][Full Text] [Related]
6. Interferon-β inhibits inflammatory responses mediators via suppression of iNOS signaling pathway in PBMCs from patients with primary Sjögren's syndrome.
Benchabane S; Belkhelfa M; Belguendouz H; Zidi S; Boudjelida A; Youinou P; Touil-Boukoffa C
Inflammopharmacology; 2018 Oct; 26(5):1165-1174. PubMed ID: 29869303
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the deep immune profiling of B cell subsets between healthy adults and Sjögren's syndrome.
Feng R; Zhao J; Sun F; Miao M; Sun X; He J; Li Z
Ann Med; 2022 Dec; 54(1):472-483. PubMed ID: 35098838
[TBL] [Abstract][Full Text] [Related]
8. B cell subsets and dysfunction of regulatory B cells in IgG4-related diseases and primary Sjögren's syndrome: the similarities and differences.
Lin W; Jin L; Chen H; Wu Q; Fei Y; Zheng W; Wang Q; Li P; Li Y; Zhang W; Zhao Y; Zeng X; Zhang F
Arthritis Res Ther; 2014 May; 16(3):R118. PubMed ID: 24887143
[TBL] [Abstract][Full Text] [Related]
9. IL-17-producing double-negative T cells are expanded in the peripheral blood, infiltrate the salivary gland and are partially resistant to corticosteroid therapy in patients with Sjögren's syndrome.
Alunno A; Bistoni O; Bartoloni Bocci E; Caterbi S; Bigerna B; Pucciarini A; Tabarrini A; Mannucci R; Beghelli D; Falini B; Gerli R
Reumatismo; 2013 Oct; 65(4):192-8. PubMed ID: 24192564
[TBL] [Abstract][Full Text] [Related]
10. SLAMF3 promotes Th17 differentiation and is reversed by iguratimod through JAK1/STAT3 pathway in primary Sjögren's syndrome.
Hu P; Cai J; Yang C; Xu L; Ma S; Song H; Yang P
Int Immunopharmacol; 2024 Jan; 126():111282. PubMed ID: 38061117
[TBL] [Abstract][Full Text] [Related]
11. Alleviating effect of paeoniflorin-6'-O-benzene sulfonate in antigen-induced experimental Sjögren's syndrome by modulating B lymphocyte migration via CXCR5-GRK2-ERK/p38 signaling pathway.
Chen X; Zhang P; Liu Q; Zhang Q; Gu F; Xu S; Körner H; Wu H; Wei W
Int Immunopharmacol; 2020 Mar; 80():106199. PubMed ID: 31955068
[TBL] [Abstract][Full Text] [Related]
12. B Cell Depletion Therapy Normalizes Circulating Follicular Th Cells in Primary Sjögren Syndrome.
Verstappen GM; Kroese FG; Meiners PM; Corneth OB; Huitema MG; Haacke EA; van der Vegt B; Arends S; Vissink A; Bootsma H; Abdulahad WH
J Rheumatol; 2017 Jan; 44(1):49-58. PubMed ID: 28042126
[TBL] [Abstract][Full Text] [Related]
13. Immunisation with Coronavirus-2 vaccines induces potent antibody responses and does not aggravate the lymphocyte compartment of primary Sjögren's syndrome patients.
Steinmetz TD; de Wolff L; Terpstra JH; Visser A; Bootsma H; Kroese FGM; Verstappen GM
Clin Exp Rheumatol; 2022 Dec; 40(12):2338-2343. PubMed ID: 36063118
[TBL] [Abstract][Full Text] [Related]
14. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.
Sellam J; Miceli-Richard C; Gottenberg JE; Ittah M; Lavie F; Lacabaratz C; Gestermann N; Proust A; Lambotte O; Mariette X
Ann Rheum Dis; 2007 Jun; 66(6):790-7. PubMed ID: 17185325
[TBL] [Abstract][Full Text] [Related]
15. Regulation of cytokine production in human peripheral blood mononuclear cells and allergen-specific th cell clones by 1alpha,25-dihydroxyvitamin D3.
Rausch-Fan X; Leutmezer F; Willheim M; Spittler A; Bohle B; Ebner C; Jensen-Jarolim E; Boltz-Nitulescu G
Int Arch Allergy Immunol; 2002 May; 128(1):33-41. PubMed ID: 12037399
[TBL] [Abstract][Full Text] [Related]
16. Sirolimus therapy restores the PD-1+ICOS+Tfh:CD45RA-Foxp3
Wang Y; Guo H; Liang Z; Feng M; Wu Y; Qin Y; Zhao X; Gao C; Liu G; Luo J
Mol Immunol; 2022 Jul; 147():90-100. PubMed ID: 35523039
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of Follicular Helper T Cell-Dependent B Cell Hyperactivity by Abatacept Treatment in Primary Sjögren's Syndrome.
Verstappen GM; Meiners PM; Corneth OBJ; Visser A; Arends S; Abdulahad WH; Hendriks RW; Vissink A; Kroese FGM; Bootsma H
Arthritis Rheumatol; 2017 Sep; 69(9):1850-1861. PubMed ID: 28564491
[TBL] [Abstract][Full Text] [Related]
18. Single Cell Based Phosphorylation Profiling Identifies Alterations in Toll-Like Receptor 7 and 9 Signaling in Patients With Primary Sjögren's Syndrome.
Davies R; Sarkar I; Hammenfors D; Bergum B; Vogelsang P; Solberg SM; Gavasso S; Brun JG; Jonsson R; Appel S
Front Immunol; 2019; 10():281. PubMed ID: 30846988
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive investigation on the distribution of circulating follicular T helper cells and B cell subsets in primary Sjögren's syndrome and systemic lupus erythematosus.
Szabó K; Papp G; Szántó A; Tarr T; Zeher M
Clin Exp Immunol; 2016 Jan; 183(1):76-89. PubMed ID: 26358223
[TBL] [Abstract][Full Text] [Related]
20. Catalpol ameliorates Sjögren's Syndrome by modulating interplay of T and B cells.
Lin R; Hao D; Dong Y; Wang Y
Biomed Pharmacother; 2020 Mar; 123():109806. PubMed ID: 31951976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
